Detalhe da pesquisa
1.
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.
Gynecol Oncol
; 187: 105-112, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38759516
2.
A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.
Int J Gynecol Cancer
; 33(8): 1208-1214, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380217
3.
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 23(2): 279-291, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35033226
4.
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
Gastroenterology
; 157(5): 1413-1428.e11, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31352001
5.
Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
Mol Carcinog
; 59(8): 930-939, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367578
6.
Improved overall survival is still observed in patients receiving delayed adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
HPB (Oxford)
; 22(11): 1542-1548, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299656
7.
Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk.
Cancer Sci
; 110(6): 2022-2032, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972876
8.
Genetic variants in the liver kinase B1-AMP-activated protein kinase pathway genes and pancreatic cancer risk.
Mol Carcinog
; 58(8): 1338-1348, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30997723
9.
Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS.
Cell Commun Signal
; 17(1): 19, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30819189
10.
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204).
Oncology
; 94(1): 39-46, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29040974
11.
The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1.
J Biol Chem
; 289(7): 4009-17, 2014 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24362026
12.
Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models.
Cancer Cell
; 12(1): 52-65, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17613436
13.
Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer.
Phys Biol
; 11(6): 065002, 2014 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25427073
14.
Reassessing hepatocellular carcinoma staging in a changing patient population.
Oncology
; 86(2): 63-71, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24401634
15.
Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma.
Cancer
; 119(18): 3334-42, 2013 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23821538
16.
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.
Mol Carcinog
; 52 Suppl 1: E139-47, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23776098
17.
Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis.
Ann Surg Oncol
; 20(7): 2197-203, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23408126
18.
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma.
Ann Surg Oncol
; 20 Suppl 3: S500-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23397153
19.
The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer.
Invest New Drugs
; 31(5): 1375-83, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23645398
20.
Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma.
Histopathology
; 63(6): 841-51, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24111684